Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bone Biologics (BBLG) Non-cash Items (2016 - 2025)

Bone Biologics has reported Non-cash Items over the past 3 years, most recently at $4.4 million for Q4 2017.

  • Quarterly Non-cash Items changed 0.0% to $4.4 million in Q4 2017 from the year-ago period, while the trailing twelve-month figure was $4.4 million through Dec 2017, changed 0.0% year-over-year, with the annual reading at $4.4 million for FY2017, 0.0% changed from the prior year.
  • Non-cash Items was $4.4 million for Q4 2017 at Bone Biologics, up from $346940.0 in the prior quarter.
  • Over five years, Non-cash Items peaked at $6.2 million in Q4 2015 and troughed at $212819.0 in Q3 2016.
  • The 3-year median for Non-cash Items is $2.8 million (2016), against an average of $2.8 million.
  • The largest YoY upside for Non-cash Items was 0.0% in 2017 against a maximum downside of 73.45% in 2017.
  • A 3-year view of Non-cash Items shows it stood at $6.2 million in 2015, then dropped by 29.0% to $4.4 million in 2016, then changed by 0.0% to $4.4 million in 2017.
  • Per Business Quant, the three most recent readings for BBLG's Non-cash Items are $4.4 million (Q4 2017), $346940.0 (Q2 2017), and $1.3 million (Q1 2017).